John Bomalaski
Corporate Officer/Principal bei POLARIS GROUP
Aktive Positionen von John Bomalaski
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| POLARIS GROUP | Corporate Officer/Principal | 01.01.2007 | - |
| Direktor/Vorstandsmitglied | 15.04.2006 | - | |
EnzymeRx LLC
 EnzymeRx LLC BiotechnologyHealth Technology EnzymeRx LLC develops pegylated uricase for the treatment of resistant and refractory related indications. The company was founded by Anthony S Fiorino in 2008 and is headquartered in Paramus, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Polaris Pharmaceuticals, Inc.
 Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - | - |
| Technik-/Wissenschafts-/F&E-Leiter | 18.12.2009 | - | |
| DRX USA | Direktor/Vorstandsmitglied | - | - |
| DesigneRx Europe Ltd. | Direktor/Vorstandsmitglied | - | - |
| Polaris Group Korea Ltd. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von John Bomalaski
Ehemalige bekannte Positionen von John Bomalaski
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Pennsylvania | Corporate Officer/Principal | - | - |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | Corporate Officer/Principal | - | - |
Ausbildung von John Bomalaski
| St. Louis University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Spanien | 2 |
| Cayman Islands | 2 |
Operativ
| Director/Board Member | 5 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| POLARIS GROUP | Health Technology |
| Private Unternehmen | 5 |
|---|---|
EnzymeRx LLC
EnzymeRx LLC BiotechnologyHealth Technology EnzymeRx LLC develops pegylated uricase for the treatment of resistant and refractory related indications. The company was founded by Anthony S Fiorino in 2008 and is headquartered in Paramus, NJ. | Health Technology |
Polaris Pharmaceuticals, Inc.
Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |
| DesigneRx Europe Ltd. | |
| DRX USA | |
| Polaris Group Korea Ltd. |
- Börse
- Insiders
- John Bomalaski
- Erfahrung
